Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Completed
Eastern Cooperative Oncology Group
Phase 3
1997-03-01
RATIONALE: Giving antibiotics may be effective in preventing or controlling early infection
in patients with multiple myeloma and may improve their response to chemotherapy.
PURPOSE: This randomized clinical trial is studying antibiotics to see how well they work
compared to no antibiotics in preventing early infection in patients with multiple myeloma.
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Completed
National Cancer Institute (NCI)
Phase 3
1997-03-01
RATIONALE: Giving antibiotics may be effective in preventing or controlling early infection
in patients with multiple myeloma and may improve their response to chemotherapy.
PURPOSE: This randomized clinical trial is studying antibiotics to see how well they work
compared to no antibiotics in preventing early infection in patients with multiple myeloma.
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Completed
Gary Morrow
Phase 3
1997-03-01
RATIONALE: Giving antibiotics may be effective in preventing or controlling early infection
in patients with multiple myeloma and may improve their response to chemotherapy.
PURPOSE: This randomized clinical trial is studying antibiotics to see how well they work
compared to no antibiotics in preventing early infection in patients with multiple myeloma.
Treatment of Clogged Tympanostomy Tubes: An Off-Label Use of Dornase Alfa (Pulmozyme®)
Completed
Genentech, Inc.
Phase 4
2007-01-01
The purpose of this study is to evaluate Pulmozyme® (dornase) as compared to a standard ear
drop Floxin® (ofloxicin) to dissolve clogged tubes. This study will monitor the use of the
new drug for any problems related to the medication. Patients are being asked to be in this
study because they had tubes placed for the treatment of chronic ear infection and the
tube(s) are now clogged. Clogged tubes are a common problem found in children with tubes.
This problem occasionally is improved with ear drops like Floxin®. However, it is frequently
not improved even after this standard ear drop treatment.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
